Ridge Splitting Using Autogenous Bone Wedge Versus the Conventional Intercortical Augmentation Technique in Horizontally Deficient Anterior Maxilla
1 other identifier
interventional
20
1 country
1
Brief Summary
The current study aimed to evaluate both the quality and quantity of gained and maintained bone width after ridge splitting utilizing autogenic bone wedges versus mixed bone particles for horizontal ridge augmentation in the anterior esthetic zone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 30, 2022
CompletedFirst Submitted
Initial submission to the registry
July 24, 2024
CompletedFirst Posted
Study publicly available on registry
July 31, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2024
CompletedJuly 31, 2024
July 1, 2024
1.8 years
July 24, 2024
July 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
bone width in (mm) by cone beam pre, immediate post operative and 6 months postoperative
after ridge augmentation in both groups, the bone width will be measured immediately postoperatively and 6 months postoperatively with cone beam and the measurements of the three intervals (pre-, immediate and 6 months postoperatively) will be compared in both groups to evaluate the amount of gained and maintained bone width
6 months
Secondary Outcomes (1)
percentage of areas of new bone (%)
6 months
Study Arms (2)
intervention group
OTHERthe group using an autogenous bone wedge harvested from the chin interpositioned between split cortices in the anterior maxilla to manage the horizontal deficiency of the ridge.
control group
OTHERthe group used mixed autogenic and xenogenic bone particles that interposed between split cortices in anterior maxilla to manage the horizontal deficiency of the ridge
Interventions
autogenous bone block harvested from chin and adjusted to be wedged intercortical in split ridge
Eligibility Criteria
You may qualify if:
- All patients possessed partially edentulous anterior maxillary ridge with the following criteria
- The anterior maxillary vertical dimension was more than ten mm measured from the alveolar crest to the basal bone of the maxilla.
- The horizontal alveolar dimension varies from 3-5 mm at the crest and 6-8 mm at the basal part of the ridge measured from the labial cortex to the lingual cortex.
- All patients were free from any medical conditions that may affect bone healing .
- No local pathosis that may interfere with bone healing.
- No previous grafting procedures at the indicated edentulous ridge.
You may not qualify if:
- Patients suffering from any systemic disease that may affect bone healing. 2- Patients with less than 3mm labio palatal alveolar ridge width. 3- Ridge with inadequate vertical bone height. 4- Presence of any local pathosis that may interfere with bone healing. 5- Patients unable to continue the whole follow up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
oral and maxillo facial Surgery Department; Faculty of dentistry, Cairo University.
Cairo, Egypt
Related Publications (2)
Atef M, Osman AH, Hakam M. Autogenous interpositional block graft vs onlay graft for horizontal ridge augmentation in the mandible. Clin Implant Dent Relat Res. 2019 Aug;21(4):678-685. doi: 10.1111/cid.12809. Epub 2019 Jul 1.
PMID: 31260166BACKGROUNDOmara M, Mekhemer S, Mansour S, Ahmed Y. Ridge splitting using autogenous bone wedge versus the conventional intercortical augmentation technique in horizontally deficient anterior maxilla: a randomized clinical trial. BMC Oral Health. 2025 Jun 21;25(1):955. doi: 10.1186/s12903-025-06345-z.
PMID: 40544250DERIVED
Related Links
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- masiomara
Study Record Dates
First Submitted
July 24, 2024
First Posted
July 31, 2024
Study Start
October 30, 2022
Primary Completion
August 30, 2024
Study Completion
December 30, 2024
Last Updated
July 31, 2024
Record last verified: 2024-07